
|Videos|July 21, 2023
Impact of Personalized Dosing of Faricimab on Treatment Outcomes in nAMD
Author(s)Varun Chaudhary, MD, FRCS(C)
Dr Varun Chaudhary discusses the impact of personalized treat-and-extend-based dosing on visual and anatomic outcomes of faricimab in the TENAYA and LUCERNE clinical trials in neovascular AMD.
Advertisement
Episodes in this series
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Retina World Congress 2026: Identifying real-world durability gaps in wet AMD treatment
2
Retina World Congress 2026: Diagnosing macular telangiectasia in a field of mimickers
3
Retina World Congress 2026: Rethinking macular hole surgery without gas tamponade
4
Retina World Congress 2026: The case for earlier surgical intervention in diabetic macular edema
5






















